mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.096 |
0.006 |
mRNA |
tivozanib |
GDSC1000 |
pan-cancer |
AAC |
-0.096 |
0.006 |
mRNA |
Rapamycin |
CTRPv2 |
pan-cancer |
AAC |
0.097 |
0.007 |
mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.007 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.007 |
mRNA |
WZ3105 |
GDSC1000 |
pan-cancer |
AAC |
-0.082 |
0.007 |
mRNA |
skepinone-L |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.007 |
mRNA |
VX-11e |
GDSC1000 |
pan-cancer |
AAC |
-0.091 |
0.007 |
mRNA |
pac-1 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.008 |
mRNA |
BRD-K34222889 |
CTRPv2 |
pan-cancer |
AAC |
0.087 |
0.008 |